https://www.sciencedaily.com/news/health_medicine/pneumonia/ Read the latest research on pneumonia, including how it is contracted, new treatments and more. en-us Mon, 20 Apr 2026 02:42:16 EDT Mon, 20 Apr 2026 02:42:16 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/pneumonia/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260416071953.htm Scientists have uncovered a surprising twist in how bacteria share genes—including those that spread antibiotic resistance. Tiny virus-like particles called gene transfer agents (GTAs), once ancient viral invaders, have been repurposed by bacteria into delivery systems that shuttle DNA between neighboring cells. The study reveals a key control hub of three genes, dubbed LypABC, that triggers bacterial cells to burst open and release these DNA-packed couriers. Fri, 17 Apr 2026 07:44:05 EDT https://www.sciencedaily.com/releases/2026/04/260416071953.htm https://www.sciencedaily.com/releases/2026/02/260217005717.htm Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR-based tool that doesn’t just fight resistant bacteria—it can actively strip away their drug resistance. Inspired by gene drives used in insects, the technology spreads a genetic “fix” through bacterial populations, even inside stubborn biofilms that shield microbes from antibiotics. Wed, 18 Feb 2026 03:08:21 EST https://www.sciencedaily.com/releases/2026/02/260217005717.htm https://www.sciencedaily.com/releases/2026/02/260206020850.htm Scientists in Australia have uncovered a clever new way to fight some of the most dangerous drug-resistant bacteria by targeting a sugar that exists only on bacterial cells. By designing antibodies that recognize this unique sugar, researchers were able to guide the immune system to attack and eliminate deadly infections that normally shrug off antibiotics. Fri, 06 Feb 2026 04:09:04 EST https://www.sciencedaily.com/releases/2026/02/260206020850.htm https://www.sciencedaily.com/releases/2025/11/251109013246.htm Scientists have turned to advanced AI to decode the intricate ecosystem of gut bacteria and their chemical signals. Using a Bayesian neural network called VBayesMM, researchers can now identify genuine biological links rather than random correlations. The system has already outperformed traditional models in studies of obesity, sleep disorders, and cancer. Mon, 10 Nov 2025 01:21:30 EST https://www.sciencedaily.com/releases/2025/11/251109013246.htm https://www.sciencedaily.com/releases/2025/11/251102205009.htm Penn State scientists uncovered an ancient bacterial defense where dormant viral DNA helps bacteria fight new viral threats. The enzyme PinQ flips bacterial genes to create protective proteins that block infection. Understanding this mechanism could lead to breakthroughs in antivirals, antibiotic alternatives, and industrial microbiology. Mon, 03 Nov 2025 09:05:12 EST https://www.sciencedaily.com/releases/2025/11/251102205009.htm https://www.sciencedaily.com/releases/2025/05/250522125153.htm Researchers uncover a notorious cholera strain that contains sophisticated immune systems to fend off viruses, which potentially helped it to fuel a devastating epidemic across Latin America. Thu, 22 May 2025 12:51:53 EDT https://www.sciencedaily.com/releases/2025/05/250522125153.htm https://www.sciencedaily.com/releases/2025/05/250507125835.htm Researchers reviewed US national fatal crash data (2016-2021) and examined the vehicle age and driver assistance technologies of vehicles driven by teen and middle-aged drivers, and their associations with driver deaths during fatal crashes. Wed, 07 May 2025 12:58:35 EDT https://www.sciencedaily.com/releases/2025/05/250507125835.htm https://www.sciencedaily.com/releases/2025/04/250403122814.htm Certain antibiotic-resistant infections could be treated with precision medicine in the future, thanks to a new resource mapping plasmids the ultimate vehicle of rapid bacterial evolution. Thu, 03 Apr 2025 12:28:14 EDT https://www.sciencedaily.com/releases/2025/04/250403122814.htm https://www.sciencedaily.com/releases/2025/03/250324113856.htm Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria--such as how they synthesise their protective capsules--is essential for developing new strategies to counter antibiotic resistance. Mon, 24 Mar 2025 11:38:56 EDT https://www.sciencedaily.com/releases/2025/03/250324113856.htm https://www.sciencedaily.com/releases/2025/03/250313130801.htm A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of this antibody leads to an overgrowth of gut microbiota, triggering an excessive and sustained immune system response, which ultimately becomes exhausted and fails to respond effectively to vaccines. Thu, 13 Mar 2025 13:08:01 EDT https://www.sciencedaily.com/releases/2025/03/250313130801.htm https://www.sciencedaily.com/releases/2025/02/250217133353.htm A nut used in herbal tea has become a hydrogel perfect for a variety of biomedical uses in new research. Scientists created a malva nut hydrogel for medical uses ranging from wound care to ECG readings. The research doesn't rely on the rumored health benefits of the nuts -- in China, they're known as the sore throat remedy Pangdahai (PDH) -- but for their ability to swell 20 times their weight in water. Mon, 17 Feb 2025 13:33:53 EST https://www.sciencedaily.com/releases/2025/02/250217133353.htm https://www.sciencedaily.com/releases/2025/02/250206155344.htm The researchers showed that when curcumin is intentionally given to bacteria as food and then activated by light, it can trigger deleterious reactions within these microbes, eventually killing them. This process, they demonstrated, reduces the number of antibiotic-resistant strains and renders conventional antibiotics effective again. Thu, 06 Feb 2025 15:53:44 EST https://www.sciencedaily.com/releases/2025/02/250206155344.htm https://www.sciencedaily.com/releases/2024/11/241125125026.htm With the rapid development of antibiotics in the 1930s, phage therapy -- using viruses known as bacteriophages or phages to tackle bacterial infections -- fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat bacterial infections, phage therapy is once again sparking interest among physicians and scientists -- although it remains complex in practice because of the great diversity and specificity of phages. Mon, 25 Nov 2024 12:50:26 EST https://www.sciencedaily.com/releases/2024/11/241125125026.htm https://www.sciencedaily.com/releases/2024/11/241115124834.htm Researchers discovered an unexpected link between zinc deficiency, the pro-inflammatory cytokine interleukin-13 (IL-13), and Acinetobacter baumannii lung infection and demonstrated that blocking IL-13 prevented infection-associated death in an animal model. The findings suggest that anti-IL-13 antibodies, which are FDA-approved for use in humans, may protect against bacterial pneumonia in patients with zinc deficiency. Fri, 15 Nov 2024 12:48:34 EST https://www.sciencedaily.com/releases/2024/11/241115124834.htm https://www.sciencedaily.com/releases/2024/10/241029143831.htm Doctors struggle to accurately predict pneumonia patients' prognoses and determine the most effective treatments. Now, by applying a sophisticated machine-learning approach to electronic health records (EHRs) of patients with pneumonia, researchers uncovered five distinct clinical states in pneumonia. Tue, 29 Oct 2024 14:38:31 EDT https://www.sciencedaily.com/releases/2024/10/241029143831.htm https://www.sciencedaily.com/releases/2024/10/241024145501.htm Researchers discovered potentially far-reaching effects of a particular gut bacterium that was linked to better growth in Bangladeshi children receiving a therapeutic food designed to nurture healthy gut microbes. A strain of the bacterium harbored in the children's gut microbial communities possessed a previously unknown gene capable of producing and metabolizing key molecules involved in regulating many important functions ranging from appetite, immune responses, neuronal function, and the ability of pathogenic bacteria to produce disease. Thu, 24 Oct 2024 14:55:01 EDT https://www.sciencedaily.com/releases/2024/10/241024145501.htm https://www.sciencedaily.com/releases/2024/10/241016115915.htm Researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells. Wed, 16 Oct 2024 11:59:15 EDT https://www.sciencedaily.com/releases/2024/10/241016115915.htm https://www.sciencedaily.com/releases/2024/09/240926132129.htm Research has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. Using genetic and functional approaches, the researchers managed to unravel how these antibodies interact with antigens on the bacterial surface. They also found that some of these novel antibodies act synergistically to neutralize this pathogen. Thu, 26 Sep 2024 13:21:29 EDT https://www.sciencedaily.com/releases/2024/09/240926132129.htm https://www.sciencedaily.com/releases/2024/08/240829132359.htm Salmonella enterica causes disease in 1.2 million people in the U.S. every year. A new study found that Salmonella contamination is enhanced by high humidity and plant disease. Thu, 29 Aug 2024 13:23:59 EDT https://www.sciencedaily.com/releases/2024/08/240829132359.htm https://www.sciencedaily.com/releases/2024/08/240806131331.htm An AI-based analysis of over 2 million hospital visits has found that most of the time, a pneumonia diagnosis made in the hospital will change from a patient's entrance to their discharge -- either because someone who was initially diagnosed with pneumonia ended up with a different final diagnosis, or because a final diagnosis of pneumonia was missed when a patient entered the hospital. Tue, 06 Aug 2024 13:13:31 EDT https://www.sciencedaily.com/releases/2024/08/240806131331.htm https://www.sciencedaily.com/releases/2024/07/240716122720.htm Researchers have developed a strategy to identify new antimicrobial drugs with therapeutic promise from bacterial datasets, providing clues for discovering alternatives to traditional antibiotics. Tue, 16 Jul 2024 12:27:20 EDT https://www.sciencedaily.com/releases/2024/07/240716122720.htm https://www.sciencedaily.com/releases/2024/07/240703131714.htm Combining genomic data and human travel patterns over a 14-year period in South Africa reveals key insights into the spread, evolution and resistance patterns of a major bacterium behind pneumonia and meningitis globally. Wed, 03 Jul 2024 13:17:14 EDT https://www.sciencedaily.com/releases/2024/07/240703131714.htm https://www.sciencedaily.com/releases/2024/06/240613161125.htm Researchers are unlocking the mystery of how bacteria harness viruses to wipe out the competition. The answers could help spur the development of alternatives to antibiotics. Thu, 13 Jun 2024 16:11:25 EDT https://www.sciencedaily.com/releases/2024/06/240613161125.htm https://www.sciencedaily.com/releases/2024/05/240529144212.htm Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut. The drug, called lolamicin, also warded off secondary infections with Clostridioides difficile, a common and dangerous hospital-associated bacterial infection, and was effective against more than 130 multidrug-resistant bacterial strains in cell culture. Wed, 29 May 2024 14:42:12 EDT https://www.sciencedaily.com/releases/2024/05/240529144212.htm https://www.sciencedaily.com/releases/2024/04/240424111615.htm Researchers have created a new vaccine candidate to treat staph and MRSA infections. Wed, 24 Apr 2024 11:16:15 EDT https://www.sciencedaily.com/releases/2024/04/240424111615.htm https://www.sciencedaily.com/releases/2024/04/240415110512.htm Use of antibiotics provided no measurable impact on the severity or duration of coughs even if a bacterial infection was present, finds a large, prospective study of people who sought treatment in U.S. primary or urgent care settings for lower-respiratory tract infections. Mon, 15 Apr 2024 11:05:12 EDT https://www.sciencedaily.com/releases/2024/04/240415110512.htm https://www.sciencedaily.com/releases/2024/03/240313210234.htm A new test diagnoses patients with melioidosis within hours, rather than days, meaning they can receive the correct antibiotics faster. Wed, 13 Mar 2024 21:02:34 EDT https://www.sciencedaily.com/releases/2024/03/240313210234.htm https://www.sciencedaily.com/releases/2024/03/240305134236.htm Bacteria can be tricked into sending death signals to stop the growth of their slimy, protective homes that lead to deadly infections, a new study demonstrates. The discovery could someday be harnessed as an alternative to antibiotics for treating difficult infections. The researchers used the messengers, which they named death extracellular vesicles (D-EVs), to reduce growth of the bacterial communities by up to 99.99% in laboratory experiments. Tue, 05 Mar 2024 13:42:36 EST https://www.sciencedaily.com/releases/2024/03/240305134236.htm https://www.sciencedaily.com/releases/2024/02/240221213859.htm About a decade ago, researchers began to observe a recurring challenge in their research: Some of the compounds they were developing to harness energy from bacteria were instead killing the microbes. Not good if the objective of the project was to harness the metabolism of living bacteria to produce electricity. Wed, 21 Feb 2024 21:38:59 EST https://www.sciencedaily.com/releases/2024/02/240221213859.htm https://www.sciencedaily.com/releases/2024/02/240206183543.htm Researchers have identified a new approach to controlling bacterial infections. The team found a way to turn on a vital bacterial defense mechanism to fight and manage bacterial infections. The defense system, called cyclic oligonucleotide-based antiphage signaling system (CBASS), is a natural mechanism used by certain bacteria to protect themselves from viral attacks. Bacteria self-destruct as a means to prevent the spread of virus to other bacterial cells in the population. Tue, 06 Feb 2024 18:35:43 EST https://www.sciencedaily.com/releases/2024/02/240206183543.htm https://www.sciencedaily.com/releases/2024/01/240119122721.htm One in three children who suffer from bacterial meningitis live with permanent neurological disabilities due to the infection. Fri, 19 Jan 2024 12:27:21 EST https://www.sciencedaily.com/releases/2024/01/240119122721.htm https://www.sciencedaily.com/releases/2023/12/231218125919.htm Researchers have found an inexpensive tool that may help reduce rates of pneumonia for hospitalized patients -- and it comes with bristles on one end. A new study examined whether daily toothbrushing among hospitalized patients is associated with lower rates of hospital-acquired pneumonia and other outcomes. Mon, 18 Dec 2023 12:59:19 EST https://www.sciencedaily.com/releases/2023/12/231218125919.htm https://www.sciencedaily.com/releases/2023/12/231205170648.htm Sniffles, snorts and blows of runny noses are the hallmarks of cold and flu season -- and that increase in mucus is exactly what bacteria use to mount a coordinated attack on the immune system, according to a new study. The team found that the thicker the mucus, the better the bacteria are able to swarm. The findings could have implications for treatments that reduce the ability of bacteria to spread. Tue, 05 Dec 2023 17:06:48 EST https://www.sciencedaily.com/releases/2023/12/231205170648.htm https://www.sciencedaily.com/releases/2023/11/231128132429.htm A research team has successfully developed a novel pneumococcal vaccine by combining the team's proprietary mucosal vaccine technology with pneumococcal surface proteins that can cover a wide range of serotypes. Experiments were conducted using mice and macaques and it was confirmed that pneumonia caused by pneumococcal infection was clearly suppressed in the target groups of animals inoculated with the vaccine. Tue, 28 Nov 2023 13:24:29 EST https://www.sciencedaily.com/releases/2023/11/231128132429.htm https://www.sciencedaily.com/releases/2023/11/231128001424.htm A research team has successfully developed a novel pneumococcal vaccine by combining the team's proprietary mucosal vaccine technology with pneumococcal surface proteins that can cover a wide range of serotypes. Experiments were conducted using mice and macaques and it was confirmed that pneumonia caused by pneumococcal infection was clearly suppressed in the target groups of animals inoculated with the vaccine. Tue, 28 Nov 2023 00:14:24 EST https://www.sciencedaily.com/releases/2023/11/231128001424.htm https://www.sciencedaily.com/releases/2023/11/231113111818.htm Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat, according to a new national survey. Mon, 13 Nov 2023 11:18:18 EST https://www.sciencedaily.com/releases/2023/11/231113111818.htm https://www.sciencedaily.com/releases/2023/09/230912165714.htm Pneumonia is an infection of the lung alveoli caused by bacteria, viruses or fungi. It is one of the leading causes of morbidity and mortality worldwide, representing a clinical and economic burden and a global public health problem. The microbial ecosystem (or microbiome) of the human respiratory tract colonizes different niches. The respiratory tract microbiome is of interest to scientists as it contributes to human health by stimulating the immune system and protecting against infection by pathogens. Scientists have now demonstrated that the microbiome composition, pathogen load and clinical interventions influence the severity of bacterial pneumonia caused by Legionella pneumophila. Tue, 12 Sep 2023 16:57:14 EDT https://www.sciencedaily.com/releases/2023/09/230912165714.htm https://www.sciencedaily.com/releases/2023/08/230830130846.htm Researchers applied a new technology to generate the full inventory of mutations in the bacterial species Escherichia coli where the antibiotic rifampicin attaches to and disables an essential bacterial enzyme known as RNA polymerase (RNAP). Wed, 30 Aug 2023 13:08:46 EDT https://www.sciencedaily.com/releases/2023/08/230830130846.htm https://www.sciencedaily.com/releases/2023/08/230829125956.htm Selective targeting of cancerous cells poses major clinical challenges during cancer therapy. However, this limitation can be overcome by using bioengineered bacteria with highly optimized chemical modifications. A recent study demonstrates the use of chemically modified purple photosynthetic bacteria for the successful detection and elimination of colon cancer cells in a mouse model. The study also sheds light on the underlying mechanism of action. Tue, 29 Aug 2023 12:59:56 EDT https://www.sciencedaily.com/releases/2023/08/230829125956.htm https://www.sciencedaily.com/releases/2023/08/230822111734.htm A new powerful antibiotic, isolated from bacteria that could not be studied before, seems capable of combating harmful bacteria and even multi-resistant 'superbugs'. Named Clovibactin, the antibiotic appears to kill bacteria in an unusual way, making it more difficult for bacteria to develop any resistance against it. Tue, 22 Aug 2023 11:17:34 EDT https://www.sciencedaily.com/releases/2023/08/230822111734.htm https://www.sciencedaily.com/releases/2023/08/230816170628.htm Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer's disease, according to new research. Wed, 16 Aug 2023 17:06:28 EDT https://www.sciencedaily.com/releases/2023/08/230816170628.htm https://www.sciencedaily.com/releases/2023/08/230814174547.htm Advanced microscopy techniques give scientists valuable clues for how to fight an enzyme that is leading to a rise in cases of antibiotic-resistant bacterial infections worldwide. Mon, 14 Aug 2023 17:45:47 EDT https://www.sciencedaily.com/releases/2023/08/230814174547.htm https://www.sciencedaily.com/releases/2023/08/230804123751.htm Researchers have discovered a previously unknown mechanism by which bacteria share their genetic material through virus parasites. The insights could help scientists to better understand how bacteria rapidly adapt and evolve, and how they become more virulent and resistant to antibiotics. Fri, 04 Aug 2023 12:37:51 EDT https://www.sciencedaily.com/releases/2023/08/230804123751.htm https://www.sciencedaily.com/releases/2023/06/230627225150.htm Recurrent bouts of systemic lupus erythematosus, marked by the body's immune system attack of its own tissues, closely tracked with measureable upticks in growth in the gut of a certain species of bacteria. Tue, 27 Jun 2023 22:51:50 EDT https://www.sciencedaily.com/releases/2023/06/230627225150.htm https://www.sciencedaily.com/releases/2023/06/230623161134.htm Researchers report that, in laboratory cultures and animal models, a drug significantly reduces the ability of bacteria to develop antibiotic resistance, which might prolong antibiotic effectiveness. Fri, 23 Jun 2023 16:11:34 EDT https://www.sciencedaily.com/releases/2023/06/230623161134.htm https://www.sciencedaily.com/releases/2023/06/230605181325.htm Genes that make bacteria resistant to antibiotics are much more widespread in our environment than was previously realized. A new study shows that bacteria in almost all environments carry resistance genes, with a risk of them spreading and aggravating the problem of bacterial infections that are untreatable with antibiotics. Mon, 05 Jun 2023 18:13:25 EDT https://www.sciencedaily.com/releases/2023/06/230605181325.htm https://www.sciencedaily.com/releases/2023/04/230425111250.htm Typically T cells of the immune system respond to a specific feature (antigen) of a microbe, thereby generating protective immunity. Scientists have discovered an exception to this rule. Namely, a group of divergent bacterial pathogens, including pneumococci, all share a small highly conserved protein sequence, which is both presented and recognized by human T cells in a conserved population-wide manner. Tue, 25 Apr 2023 11:12:50 EDT https://www.sciencedaily.com/releases/2023/04/230425111250.htm https://www.sciencedaily.com/releases/2023/04/230417142525.htm Many disease-causing bacteria like Streptococcus pneumoniae (S. pneumoniae) are encased in a sugar layer called the capsular polysaccharide (CPS). This layer is often essential for infections. In a ground-breaking discovery, features of the CPS that help the bacteria to colonize the human respiratory tract were identified. The research showed that the structures of the CPS capsule and its types of linkages and combinations matter greatly in allowing the bacteria to better attach and survive on the lining of the upper and lower human respiratory tracts. Mon, 17 Apr 2023 14:25:25 EDT https://www.sciencedaily.com/releases/2023/04/230417142525.htm https://www.sciencedaily.com/releases/2023/04/230412131152.htm Developing and testing new treatments or vaccines for humans almost always requires animal trials, but these experiments can sometimes take years to complete and can raise ethical concerns about the animals' treatment. Now, researchers reporting in ACS Central Science have developed a new testing platform that encapsulates B cells -- some of the most important components of the immune system -- into miniature 'organoids' to make vaccine screening quicker and greatly reduce the number of animals needed. Wed, 12 Apr 2023 13:11:52 EDT https://www.sciencedaily.com/releases/2023/04/230412131152.htm https://www.sciencedaily.com/releases/2023/04/230412131104.htm Researchers have discovered that Staphylococcus aureus can rapidly evolve within a single person's microbiome. They found that in people with eczema, S. aureus tends to evolve to a variant with a mutation in a specific gene that helps it grow faster on the skin. Wed, 12 Apr 2023 13:11:04 EDT https://www.sciencedaily.com/releases/2023/04/230412131104.htm https://www.sciencedaily.com/releases/2023/04/230411105857.htm Babies tumble about with more than 200 previously unknown viral families within their intestines. This large number comes as a surprise to researchers, who closely studied the diapers of 647 Danish babies and made this mapping. These viruses most likely play an important role in protecting children from chronic diseases. Tue, 11 Apr 2023 10:58:57 EDT https://www.sciencedaily.com/releases/2023/04/230411105857.htm https://www.sciencedaily.com/releases/2023/04/230405112156.htm Researchers are studying the genes of superbugs to aid the development of new and effective treatments for drug-resistant bacterial infections. Superbugs are characterized as infection-causing bacteria resistant to treatment with antibiotics. Wed, 05 Apr 2023 11:21:56 EDT https://www.sciencedaily.com/releases/2023/04/230405112156.htm https://www.sciencedaily.com/releases/2023/03/230316140934.htm Pneumococcal disease leads to over three million hospitalizations and hundreds of thousands of deaths annually. A new study suggests that the FDA-approved drug Fomepizole may reduce disease severity in the lungs of mice with some forms of bacterial pneumonia and enhance the efficacy of the antibiotic erythromycin as well. Thu, 16 Mar 2023 14:09:34 EDT https://www.sciencedaily.com/releases/2023/03/230316140934.htm https://www.sciencedaily.com/releases/2023/03/230308084349.htm Researchers found opioids were responsible for more than half of all fatal poisonings in children ages 5 and younger, more than double the proportion of fatal poisonings caused by opioids in 2005. Additionally, over-the-counter drugs still contribute to fatal poisonings in this age group despite increased regulation. Wed, 08 Mar 2023 08:43:49 EST https://www.sciencedaily.com/releases/2023/03/230308084349.htm https://www.sciencedaily.com/releases/2023/03/230301120831.htm New research in mice shows bacteria hijack communication between nerve and immune cells in the meninges -- the protective layers that shield the brain from infection. The experiments detail step by step how bacteria activate pain receptors and initiate a signaling cascade that disables immune cells and culminates in bacterial invasion of the brain. The findings provide much-needed understanding into a critical window during the early stages of bacterial invasion when intervention could halt the spread of infection. The results point to therapeutic pathways for new treatments of bacterial meningitis, an often-fatal disease that can leave survivors with serious neurologic damage. Wed, 01 Mar 2023 12:08:31 EST https://www.sciencedaily.com/releases/2023/03/230301120831.htm https://www.sciencedaily.com/releases/2023/02/230216161214.htm In a potential game changer for the treatment of superbugs, a new class of antibiotics was developed that cured mice infected with bacteria deemed nearly 'untreatable' in humans -- and resistance to the drug was virtually undetectable. Thu, 16 Feb 2023 16:12:14 EST https://www.sciencedaily.com/releases/2023/02/230216161214.htm https://www.sciencedaily.com/releases/2023/02/230208125111.htm A new study reveals how resistance to bacteraemic pneumonia is provided by a unique subset of lung T regulatory cells. Wed, 08 Feb 2023 12:51:11 EST https://www.sciencedaily.com/releases/2023/02/230208125111.htm https://www.sciencedaily.com/releases/2023/02/230206104139.htm The number of unprovoked shark attacks worldwide decreased last year, tying with 2020 for the fewest number of reported incidents in the last 10 years. There were a total of 57 unprovoked bites in 2022, most of which occurred in the United States and Australia. Of these, five attacks were fatal, down from nine deaths in 2021 and 10 the year prior. Mon, 06 Feb 2023 10:41:39 EST https://www.sciencedaily.com/releases/2023/02/230206104139.htm https://www.sciencedaily.com/releases/2022/12/221222101017.htm Pathogens such as SARS-CoV-2 and pneumococcus can cause severe pneumonia. If the airways then fill with fluid, the patient risks developing acute respiratory distress syndrome. Researchers have now discovered the molecular mechanisms that trigger fluid accumulation in the lungs. This also led them to discover a potential new therapy: A cystic fibrosis drug proved effective in their laboratory experiments, raising hope that this could be used to treat pneumonia regardless of the pathogen that caused it. Thu, 22 Dec 2022 10:10:17 EST https://www.sciencedaily.com/releases/2022/12/221222101017.htm https://www.sciencedaily.com/releases/2022/11/221121213544.htm Infectious diseases experts warn of the rising threat and apparent spread of disease-causing fungi outside their traditional hot spots. Fungal lung infections are commonly misdiagnosed, leading to delays in treatment and increase in antimicrobial resistance in the community. Mon, 21 Nov 2022 21:35:44 EST https://www.sciencedaily.com/releases/2022/11/221121213544.htm